TEKLA CAPITAL MANAGEMENT LLC – BioCryst Pharmaceuticals, Inc. Transaction History
TEKLA CAPITAL MANAGEMENT LLC portfolio value:
$4.40M
portfolio value
TEKLA CAPITAL MANAGEMENT LLC quarter portfolio value change:
+19.09%
quarter
BioCryst Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +26.00% | 72.13K shares | 1.47M | $12.6 | 349.57K |
| Q2 2022 | share | Increase | +41.10% | 80.80K shares | -262K | $10.58 | 277.43K |
| Q1 2022 | share | Increase | 0.00% | 196.62K shares | 3.19M | $16.26 | 196.62K |
| Q1 2018 | share | Decrease | -100.00% | -449.25K shares | -2.20M | $4.77 | 0 |
| Q4 2017 | share | Increase | +38.98% | 126K shares | 512K | $4.91 | 449.25K |
| Q3 2017 | share | Increase | 0.00% | 323.25K shares | 1.69M | $5.24 | 323.25K |